Second generation antipsychotic-induced mitochondrial alterations: Implications for increased risk of metabolic syndrome in patients with schizophrenia
Giselli Scaini, João Quevedo, Dawn Velligan, David L. Roberts, Henriette Raventos, Consuelo Walss-Bass
Dive into the research topics of 'Second generation antipsychotic-induced mitochondrial alterations: Implications for increased risk of metabolic syndrome in patients with schizophrenia'. Together they form a unique fingerprint.